[Inflammation and host resistance against bacteria. I.--Increased resistance against Listeria monocytogenes and Salmonella typhimurium in mice, following their treatment with bradykinin, kallidin and methionyl-lysyl-bradykinin (author's transl)].
Mice pretreated with kinins are more resistant to a lethal challenge of Listeria monocytogenes. The multiplication of Listeria is decreased in the liver and spleen and the blood clearance of Salmonella typhi-murium is increased.
D000818:Animals; D001920:Bradykinin / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D007249:Inflammation / Q000276:immunology*; D007609:Kallidin / Q000494:pharmacology; D007705:Kinins / Q000494:pharmacology*; D008088:Listeriosis / Q000276:immunology*; D008099:Liver / Q000276:immunology; D008264:Macrophages / Q000502:physiology; D008297:Male; D051379:Mice; D012481:Salmonella Infections, Animal / Q000276:immunology*; D012486:Salmonella typhimurium; D013154:Spleen / Q000276:immunology
D007705:Kinins; D007609:Kallidin; D001920:Bradykinin
Inflammation et résistance antibactérienne. I.--Augmentation de la résistance des souris à l'infection par Listeria monocytogenes et Salmonella typhi-murium après traitement par la bradykinine, la kallidine et la méthionine-lysine-bradykinine.